Torrent Pharmaceuticals scheduled a post-results conference call for 22nd May 2026 to discuss Q4 and FY26 financial performance.
The call will be held at 6:30 PM IST, with dial-in numbers and a Diamond Pass registration link provided for global access.
The company intimated the exchanges that the event is a standard post-earnings investor engagement with no indication of UPSI disclosure.